Mazza A, Rigatelli G, Piva M, Rampin L, Cardaioli P, Giordan M, Roncon L, Zattoni L, Zuin M, Al-Nahhas A, Rubello D, Ramazzina E, Ravenni R, Casiglia E
Department of Internal Medicine, Santa Maria della Misericordia Hospital, Rovigo, Italy.
Minerva Cardioangiol. 2011 Dec;59(6):533-42.
In high-risk hypertensive subjects (HTs) with incidental unilateral renal artery stenosis (RAS), the effectiveness of percutaneous revascularization with stent (PR-STENT) on blood pressure (BP) and glomerular filtration rate (GFR) is not established.
Eighteen HTs aged 65.7 ± 9.2 years with angiographically diagnosed unilateral RAS (≥ 60%) were randomized to receive PR-STENT (N=9) or to NO-STENT (N=9). BP (mercury sphygmomanometer) and GFR (99mTc-DTPA clearances during renal scintigraphy) were evaluated yearly for three years. Echo-Doppler of renal arteries was performed to verify the anatomic patency and flow velocities of the reperfused artery. Analysis of variance compared BP and GFR values changes from baseline to the follow-up; differences for continuous variables were evaluated between groups with the Tukey's post hoc test after adjustment for age, change of BP between baseline and at the follow-up, GFR and body mass index (BMI).
Baseline systolic BP and GFR values were not different between groups. The significantly greater GFR increase observed in PR-STENT than in NO-STENT at univariate analysis at the end of follow-up (62.5 ± 19.2 vs. 42.24 ± 17.6, P<0.02) disappeared after adjustment for confounding factors. However, systolic BP remained significantly lower in PR-STENT than in NO-STENT (140.1 ± 4.6 vs. 170.0 ± 8.3, P<0.0001) also after adjustment for age, GFR and BMI.
PR-STENT reduces systolic BP without improving GFR. Due to the strong association between high BP and renal damage, this study raises the question on whether PR-STENT should be performed in all HTs with unilateral and incidental RAS.
在患有偶发性单侧肾动脉狭窄(RAS)的高危高血压患者(HT)中,经皮支架血管重建术(PR-STENT)对血压(BP)和肾小球滤过率(GFR)的有效性尚未确立。
18名年龄为65.7±9.2岁、经血管造影诊断为单侧RAS(≥60%)的HT被随机分为接受PR-STENT组(N = 9)或非支架组(N = 9)。连续三年每年评估血压(水银血压计)和GFR(肾闪烁显像期间的99mTc-DTPA清除率)。进行肾动脉超声多普勒检查以验证再灌注动脉的解剖通畅性和血流速度。方差分析比较从基线到随访期间的BP和GFR值变化;在对年龄、基线和随访期间的BP变化、GFR和体重指数(BMI)进行调整后,使用Tukey事后检验评估组间连续变量的差异。
两组之间的基线收缩压和GFR值无差异。在随访结束时的单变量分析中,PR-STENT组观察到的GFR增加显著大于非支架组(62.5±19.2对42.24±17.6,P<0.02),在对混杂因素进行调整后消失。然而,在对年龄、GFR和BMI进行调整后,PR-STENT组的收缩压仍显著低于非支架组(140.1±4.6对170.0±8.3,P<0.0001)。
PR-STENT可降低收缩压,但不能改善GFR。由于高血压与肾损伤之间存在密切关联,本研究提出了是否应对所有患有单侧偶发性RAS的HT进行PR-STENT治疗的问题。